Hogar

Aquest any la paraula “llar” ha cobrat un nou significat. S’ha convertit en refugi, en protecció i en presó. La il·lustració i la creativitat ens han ajudat a alliberar les nostres ments, en un moment en què els nostres cossos estaven reclosos. En aquesta exposició del Postgrau en Il·lustració creativa i tècniques de comunicació visual d’EINA trobareu les creacions que els 19 estudiants d’aquest programa han realitzat durant aquest any d’aprenentatge professional i personal. La llar, les experiències i els interessos de cada un d’ells es veuen reflectits en la seva obra i formen part del missatge que transmeten. Llar és qui ens envolta, qui ens omple i ens comprèn. Llar és família, amics i nosaltres mateixos.Este año la palabra “hogar” ha cobrado un nuevo significado. Se ha convertido en refugio, en protección y en cárcel. La ilustración y la creatividad nos han ayudado a liberar nuestras mentes, en un momento en el que nuestros cuerpos estaban recluidos. En esta exposición del Postgrado en Ilustración creativa y técnicas de comunicación visual de EINA encontraréis las creaciones que los 19 estudiantes de este programa han realizado durante este año de aprendizaje profesional y personal. El hogar, las experiencias y los intereses de cada uno de ellos se ven reflejados en su obra y forman parte del mensaje que transmiten. Hogar es quien nos rodea, quien nos llena y nos comprende. Hogar es familia, amigos y nosotros mismos.This year the word “home” has taken on a new meaning. It has become a refuge, a protection and a prison. Illustration and creativity have helped us to free our minds, at a time when our bodies were confined. In this exhibition of EINA Postgraduate Diploma in Creative Illustration and Visual Communication Techniques you will find the creations that the 19 students of this programme have made during this year of professional and personal learning. The home, the experiences and the interests of each one of them are reflected in their work and are part of the message that they transmit. Home is who surrounds us, who fills us and understands us. Home is family, friends and ourselves

CIBERER : Spanish national network for research on rare diseases: A highly productive collaborative initiative

Altres ajuts: Instituto de Salud Carlos III (ISCIII); Ministerio de Ciencia e Innovación.CIBER (Center for Biomedical Network Research; Centro de Investigación Biomédica En Red) is a public national consortium created in 2006 under the umbrella of the Spanish National Institute of Health Carlos III (ISCIII). This innovative research structure comprises 11 different specific areas dedicated to the main public health priorities in the National Health System. CIBERER, the thematic area of CIBER focused on rare diseases (RDs) currently consists of 75 research groups belonging to universities, research centers, and hospitals of the entire country. CIBERER's mission is to be a center prioritizing and favoring collaboration and cooperation between biomedical and clinical research groups, with special emphasis on the aspects of genetic, molecular, biochemical, and cellular research of RDs. This research is the basis for providing new tools for the diagnosis and therapy of low-prevalence diseases, in line with the International Rare Diseases Research Consortium (IRDiRC) objectives, thus favoring translational research between the scientific environment of the laboratory and the clinical setting of health centers. In this article, we intend to review CIBERER's 15-year journey and summarize the main results obtained in terms of internationalization, scientific production, contributions toward the discovery of new therapies and novel genes associated to diseases, cooperation with patients' associations and many other topics related to RD research

Reducing the environmental impact of surgery on a global scale: systematic review and co-prioritization with healthcare workers in 132 countries

Abstract Background Healthcare cannot achieve net-zero carbon without addressing operating theatres. The aim of this study was to prioritize feasible interventions to reduce the environmental impact of operating theatres. Methods This study adopted a four-phase Delphi consensus co-prioritization methodology. In phase 1, a systematic review of published interventions and global consultation of perioperative healthcare professionals were used to longlist interventions. In phase 2, iterative thematic analysis consolidated comparable interventions into a shortlist. In phase 3, the shortlist was co-prioritized based on patient and clinician views on acceptability, feasibility, and safety. In phase 4, ranked lists of interventions were presented by their relevance to high-income countries and low–middle-income countries. Results In phase 1, 43 interventions were identified, which had low uptake in practice according to 3042 professionals globally. In phase 2, a shortlist of 15 intervention domains was generated. In phase 3, interventions were deemed acceptable for more than 90 per cent of patients except for reducing general anaesthesia (84 per cent) and re-sterilization of ‘single-use’ consumables (86 per cent). In phase 4, the top three shortlisted interventions for high-income countries were: introducing recycling; reducing use of anaesthetic gases; and appropriate clinical waste processing. In phase 4, the top three shortlisted interventions for low–middle-income countries were: introducing reusable surgical devices; reducing use of consumables; and reducing the use of general anaesthesia. Conclusion This is a step toward environmentally sustainable operating environments with actionable interventions applicable to both high– and low–middle–income countries

Profilaxis antibiotica en la fractura subcapital del anciano

A doubJe blind study of antibiotic prophyllaxls in fractures of rhe neck uf rhe íernur in elderly patients, was made for the following reasons: - the high incidence in this hospital. - the great riske of infection in elderly patients with their associatcd pruhlerns IIf general health, nutrition... - slnce it is an example of replacement surgery, these results may be applied ro total arthroplasty of the hipo After study of the literature, and consideration of the pharmacokinetics IIf the cephalosporins most frequently used, together with the epidemiology IIf the Trauma and Orthopaedics ward of this Hospital (with computerized antibiograms), «cefaznlin» was chosen for prophyllaxis. The treatement was as follows: 1 gram intravenously 15 minutes preoperatively. 1 gram intravenously every 6 hours for the following 3 days. The incidence of infection in the control group which received no antibiotic treatement was of 12'5 %, this was reduced to 3'S % in the group receiving antibiotic prophyllaxis. It should be pointed out that all patients received the same type of prothesis and the same therapeutic route for the antibiotic. These cases were all treated by the same surgical team

Clinical features and natural history of PRKAG2 Variant Cardiac Glycogenosis

BACKGROUND PRKAG2 gene variants cause a syndrome characterized by cardiomyopathy, conduction disease, and ventricular pre-excitation. Only a small number of cases have been reported to date, and the natural history of the disease is poorly understood. OBJECTIVES The aim of this study was to describe phenotype and natural history of PRKAG2 variants in a large multicenter European cohort. METHODS Clinical, electrocardiographic, and echocardiographic data from 90 subjects with PRKAG2 variants (53% men; median age 33 years; interquartile range [IQR]: 15 to 50 years) recruited from 27 centers were retrospectively studied. RESULTS At first evaluation, 93% of patients were in New York Heart Association functional class I or II. Maximum left ventricular wall thickness was 18 +/- 8 mm, and left ventricular ejection fraction was 61 +/- 12%. Left ventricular hypertrophy (LVH) was present in 60 subjects (67%) at baseline. Thirty patients (33%) had ventricular pre-excitation or had undergone accessory pathway ablation; 17 (19%) had pacemakers (median age at implantation 36 years; IQR: 27 to 46 years), and 16 (18%) had atrial fibrillation (median age 43 years; IQR: 31 to 54 years). After a median follow-up period of 6 years (IQR: 2.3 to 13.9 years), 71% of subjects had LVH, 29% had AF, 21% required de novo pacemakers (median age at implantation 37 years; IQR: 29 to 48 years), 14% required admission for heart failure, 8% experienced sudden cardiac death or equivalent, 4% required heart transplantation, and 13% died. CONCLUSIONS PRKAG2 syndrome is a progressive cardiomyopathy characterized by high rates of atrial fibrillation, conduction disease, advanced heart failure, and life-threatening arrhythmias. Classical features of pre-excitation and severe LVH are not uniformly present, and diagnosis should be considered in patients with LVH who develop atrial fibrillation or require permanent pacemakers at a young age. (c) 2020 the American College of Cardiology Foundation. Published by Elsevier. All rights reserved.Instituto de Salud Carlos IIIInstituto de Salud Carlos IIIEuropean Commission [PI17/01941, AC16/0014, PI17/01690, PI18/01582, PT17/0015/0043]ERA-CVD Joint Transnational Call 2016 (GENPROVIC)DETECTIN-HF project (ERA-CVD framework)Wellcome TrustWellcome TrustEuropean Commission [107469/Z/15/, HICF-R6-373]National Institute for Health Research (NIHR) Royal Brompton Cardiovascular Biomedical Research UnitNIHR Imperial Biomedical Research CentreDepartment of Health, United Kingdom [HICF-R6-373]British Heart FoundationBritish Heart Foundation [SP/10/10/28431]Obra Social La Caixa FoundationLa Caixa Foundation [100010434]Fundacio Privada Daniel Bravo AndreuInstituto de Salud Carlos III - Plan Estatal de I.D.I. 2013-2016, European Regional Development Fund ("A Way of Making Europe")Spanish Ministry of Economy and Competitiveness - Plan Estatal de I.D.I. 2013-2016, European Regional Development Fund ("A Way of Making Europe")Medical Research Council Clinical Academic Research Partnership AwardUCL Hospitals NIHR Biomedical Research CentreFondazione per la Ricerca Ospedale MaggioreNIHR Great Ormond Street Hospital Biomedical Research Centreinfo:eu-repo/semantics/publishedVersio

Universidad y sociedad: comunicación, integración y colaboración con empresas e instituciones públicas y organizaciones no lucrativas. Nuevos avances

Depto. de Teorías y Análisis de la ComunicaciónFac. de Ciencias de la InformaciónFALSEsubmitte